Maishayi tea vendor in action

Alert! NAFDAC warns Nigerians against ‘Maishayi’ tea

* Medicines mixed with tea kills, lots of people dying of same in U.S. –DG

Alexander Davis | ConsumerConnect

The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerian consumers to be cautious when taking cup of tea popularly known as “Maishayi” from tea vendors.

Agency report says Prof. Mojisola Adeyeye, Director-General of NAFDAC, handed down the warning in an interview with the News Agency of Nigeria Monday, in Abuja, FCT.

Prof. Adeyeye said that the warning became necessary following information the regulatory agency received that Maishayi now mix intoxicating drugs in the tea being prepared for tea consumers.

The NAFDAC Director-General mentioned intoxicating drugs, such as tramadol, vieteling, marijuana and others, adding that consumers could lose their lives after taking tea mixed with such drugs.

“In the U.S., lots of people are dying because of these medicines. How can such medicines mixed with palm wine in the name of getting high in Nigeria?

“There are some medicines you cannot take if you have cardiovascular problem,’’ she said.

She pointed out that NAFDAC was working towards collaborating with the National Institute for Pharmaceutical Research and Development (NIPRD) to check for quality medicine in orthodox and herbal.

According to the Professor, the idea is necessary since NIPRD specialises in research, and the purpose is to ‘safeguard health of the nation.’

Adeyeye, however, called on the people to desist from harmful medicines in the name of power enhancement in whatever area they think of.

The agency’s five laboratories in Nigeria have been accredited many times and have high quality standard, she stated.

“We are going further; we want a central drug lab to be World Health Organisation (WHO) pre-qualified; we are raising our bar higher,’’ the NAFDAC boss said.

She noted that the regulatory agency would continue to sensitise people against the drugs.

Within the year, the agency would get the WHO pre-qualified central drug lab, Adeyeye stated.

Kindly Share This Story